Cryptogenic stroke - patent foramen ovale - migraine with aura: incidental triad or significant relationship? Part I

被引:2
|
作者
Lukasik, Maria [1 ]
Kozubski, Wojciech [1 ]
机构
[1] Uniwersytetu Med, Karola Marcinkowskiego Poznaniu, Katedra & Klin Neurol, PL-60355 Poznan, Poland
关键词
patent foramen ovale; cryptogenic stroke; secondary stroke prevention; TRANSIENT ISCHEMIC ATTACK; ATRIAL SEPTAL ANEURYSM; RECURRENT CEREBROVASCULAR EVENTS; PARADOXICAL EMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; MEDICAL-TREATMENT; IMAGING FINDINGS; RISK-FACTORS; PREVENTION; CLOSURE;
D O I
10.5114/ninp.2012.28259
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the first part of the paper we discuss the association between patent foramen ovale (PFO) and cryptogenic stroke. Patent foramen ovale is a remnant of the fetal circulation, found in about quarter of the general population. According to many authors, this common anatomical anomaly is of no or limited clinical significance. However, the results of some clinical studies suggest higher prevalence of PFO among subjects with either cryptogenic stroke or migraine with aura. To date, the answer to the question whether PFO is an independent risk factor for stroke remains equivocal. The purpose of this review is to discuss the role of PFO in pathophysiology of both symptomatic and asymptomatic ischaemic lesions and to analyze the coexisting factors that increase the risk of stroke. We also discuss the effectiveness of either pharmacological treatment or PFO closure in secondary stroke prevention.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [1] Patent foramen ovale and cryptogenic stroke
    Nakanishi, Koki
    Yoshiyama, Minoru
    Homma, Shunichi
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (08) : 575 - 581
  • [2] Patent Foramen Ovale and Stroke: Should PFOs Be Closed in Otherwise Cryptogenic Stroke?
    Carpenter, David A.
    Ford, Andria L.
    Lee, Jin-Moo
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (04) : 251 - 258
  • [3] Patent Foramen Ovale in Cryptogenic Stroke Incidental or Pathogenic?
    Alsheikh-Ali, Alawi A.
    Thaler, David E.
    Kent, David M.
    STROKE, 2009, 40 (07) : 2349 - 2355
  • [4] Management of patent foramen ovale in cryptogenic stroke
    Budts, Werner
    Legrand, Victor
    Peeters, Andre
    Thijs, Vincent
    ACTA CARDIOLOGICA, 2012, 67 (01) : 3 - 9
  • [5] Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter ?
    Sadrameli, Saeed S.
    Gadhia, Rajan R.
    Kabir, Rasadul
    Volpi, John J.
    CUREUS, 2018, 10 (08):
  • [6] Patent Foramen Ovale and Cryptogenic Stroke: A Matter of Age?
    Handke, Michael
    Harloff, Andreas
    Bode, Christoph
    Geibel, Annette
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (05) : 505 - 514
  • [7] The Role of Patent Foramen Ovale in Cryptogenic Stroke
    Senadim, Songul
    Bozkurt, Dilek
    Cabalar, Murat
    Bajrami, Arsida
    Yayla, Vildan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2016, 53 (01): : 63 - 66
  • [8] Cryptogenic Stroke and Patent Foramen Ovale
    Mojadidi, Mohammad K.
    Zaman, Muhammad O.
    Elgendy, Islam Y.
    Mahmoud, Ahmed N.
    Patel, Nimesh K.
    Agarwal, Nayan
    Tobis, Jonathan M.
    Meier, Bernhard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (09) : 1035 - 1043
  • [9] Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke
    West, Brian H.
    Noureddin, Nabil
    Mamzhi, Yakov
    Low, Christopher G.
    Coluzzi, Alexandra C.
    Shih, Evan J.
    Fleming, Rubine Gevorgyan
    Saver, Jeffrey L.
    Liebeskind, David S.
    Charles, Andrew
    Tobis, Jonathan M.
    STROKE, 2018, 49 (05) : 1123 - 1128
  • [10] Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
    Furlan, Anthony J.
    Reisman, Mark
    Massaro, Joseph
    Mauri, Laura
    Adams, Harold
    Albers, Gregory W.
    Felberg, Robert
    Herrmann, Howard
    Kar, Saibal
    Landzberg, Michael
    Raizner, Albert
    Wechsler, Lawrence
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) : 991 - 999